bluebird bio所有资讯

bluebird bio | SC 13G/A：超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(1.80%)

04/10 09:57 (美东)

bluebird bio | 4：持股变动声明-高管 Obenshain Andrew

03/05 17:45 (美东)

bluebird bio | 4：持股变动声明-高管 Vittiglio Joseph

03/05 17:45 (美东)

bluebird bio | 4：持股变动声明-高管 Colvin Richard A

03/05 17:45 (美东)

bluebird bio | 4：持股变动声明-高管 Krawtschuk Christopher

03/05 17:44 (美东)

bluebird bio | 4：持股变动声明-高管 Klima Thomas J

03/05 17:44 (美东)

bluebird bio | SC 13G/A：超过5%持股股东披露文件(修正)-PFM Health Sciences, LP(1.9%),PFM Health Sciences GP, LLC(1.9%)等

02/14 16:14 (美东)

bluebird bio | SC 13G/A：超过5%持股股东披露文件(修正)-TANG CAPITAL PARTNERS, LP(0.9%),Tang Capital Management, LLC(0.9%)等

02/14 16:05 (美东)

bluebird bio | SC 13G：超过5%持股股东披露文件-Alyeska Investment Group, L.P.(6.32%),Alyeska Fund GP, LLC(6.32%)等

02/14 15:56 (美东)

bluebird bio | SC 13G：超过5%持股股东披露文件-Granahan Investment Management LLC(7.38%)

02/14 09:02 (美东)

bluebird bio | SC 13G/A：超过5%持股股东披露文件(修正)-The Vanguard Group(4.61%)

02/13 17:07 (美东)

bluebird bio | SC 13G：超过5%持股股东披露文件-THE GOLDMAN SACHS GROUP, INC.(6.4 %),GOLDMAN SACHS & CO. LLC(6.4 %)

02/06 16:53 (美东)

bluebird bio | 4：持股变动声明-高管 Klima Thomas J

02/06 16:13 (美东)

bluebird bio | 4：持股变动声明-高管 Vittiglio Joseph

02/06 16:13 (美东)

bluebird bio | 4：持股变动声明-高管 Obenshain Andrew

02/06 16:13 (美东)

bluebird bio | SC 13G/A：超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(7.28%),SSGA FUNDS MANAGEMENT, INC.(6.26%)

01/25 09:14 (美东)

bluebird bio | 4：持股变动声明-高管 Obenshain Andrew

01/09 00:00 (美东)

bluebird bio | 4：持股变动声明-高管 Colvin Richard A

01/09 00:00 (美东)

bluebird bio | SC 13G/A：超过5%持股股东披露文件(修正)-BlackRock, Inc.(4.7%)

01/08 00:00 (美东)

bluebird bio | 4：持股变动声明-首席财务官 Krawtschuk Christopher

2023/12/08 16:42 (美东)